Brennan P. Greene. MD’s Clinical Trial Work Leads To Another FDA Approval! Game-Changing New Method For Glaucoma Treatment

The FDA recently approved Durysta (bimatoprost implant). Dr. Brennan Greene participated in clinical trials for this new treatment, which is the first and only sustained-release treatment of glaucoma. Durysta is implanted into the intracameral space (in front of the lens of the eye) by an eye doctor in the office setting. This eliminates the need for glaucoma …

Brennan P. Greene. MD’s Clinical Trial Work Leads To Another FDA Approval! Game-Changing New Method For Glaucoma Treatment Read More »